当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析

悦康药业

(688658)

  

流通市值:93.11亿  总市值:93.11亿
流通股本:4.50亿   总股本:4.50亿

悦康药业(688658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.55亿元,每股收益-0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益343045.39万元,未分配利润24157.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产522970.29万元,负债179924.90万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,759,106,131.971,167,382,036.87577,383,322.423,780,875,989.99
营业总成本1,936,291,861.681,269,538,108.89629,257,575.773,563,397,787
其他经营收益
营业利润-163,702,962.86-106,687,438.02-58,452,400.07159,062,907.37
利润总额-164,811,303.27-107,254,520.15-59,029,628.62152,357,607.35
净利润-154,602,737.51-102,180,151.14-49,498,244.14121,246,883.89
每股收益
其他综合收益----
综合收益总额-154,602,737.51-102,180,151.14-49,498,244.14121,246,883.89
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,528,719,010.982,640,753,385.193,037,807,721.743,157,931,976.13
非流动资产:
非流动资产合计2,700,983,923.052,648,577,451.182,573,524,520.42,580,180,448.59
资产总计5,229,702,934.035,289,330,836.375,611,332,242.145,738,112,424.72
流动负债:
流动负债合计1,375,169,644.441,331,188,204.331,401,752,107.41,505,511,582.12
非流动负债:
非流动负债合计424,079,351.47475,366,107.55674,121,703.25647,644,166.97
负债合计1,799,248,995.911,806,554,311.882,075,873,810.652,153,155,749.09
所有者权益(或股东权益):
归属于母公司股东权益合计3,429,651,990.123,478,800,821.563,528,358,831.943,577,629,966.77
股东权益合计3,430,453,938.123,482,776,524.493,535,458,431.493,584,956,675.63
负债和股东权益合计5,229,702,934.035,289,330,836.375,611,332,242.145,738,112,424.72
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,099,678,821.161,474,171,331.07701,625,737.654,362,044,451.4
经营活动现金流出小计1,931,344,531.581,481,393,781.07620,584,104.463,923,803,798.91
经营活动产生的现金流量净额168,334,289.58-7,222,45081,041,633.19438,240,652.49
投资活动产生的现金流量:
投资活动现金流入小计322,333,602.09191,731,484.6965,938,894.02849,037.86
投资活动现金流出小计723,921,992.41444,903,020.9367,707,427.51546,607,767.73
投资活动产生的现金流量净额-401,588,390.32-253,171,536.24-1,768,533.49-545,758,729.87
筹资活动产生的现金流量:
筹资活动现金流入小计128,688,063.9128,588,063.975,588,063.9649,010,636.01
筹资活动现金流出小计152,003,952.17124,583,987.5111,857,511.31677,470,460.5
筹资活动产生的现金流量净额-23,315,888.274,004,076.3963,730,552.59-28,459,824.49
汇率变动对现金及现金等价物的影响169,760.33107,617.2344,062.23263,852.38
现金及现金等价物净增加额-256,400,228.68-256,282,292.62143,047,714.52-135,714,049.49
期末现金及现金等价物余额981,418,912.12981,536,848.181,380,859,375.771,237,819,140.8
补充资料:
现金及现金等价物的净增加额--256,282,292.62--135,714,049.49
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券余汝意0.110.461.252025-08-30
TOP↑